Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05250830 · ClinicalTrials.gov registry record · NA
TrueRelief Efficacy for Post-cesarean Pain (ELECTRON)
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT05250830 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 134 participants.
The verdict
NCT05250830, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
This is a randomized trial of 134 individualized post-cesarean delivery who will be randomized to twice daily use of non-invasive bioelectronic treatment with TrueRelief device or identical appearing sham device for post-cesarean pain management.
Interventions
- DEVICE TrueRelief device
- DEVICE Sham TrueRelief device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2022-04-18 |
| Est. Completion | 2023-04-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05250830
The ClinicalTrials.gov registry entry for NCT05250830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TrueRelief device is the first listed.
NCT05250830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05250830 about?
NCT05250830 is a clinical study titled "TrueRelief Efficacy for Post-cesarean Pain (ELECTRON)". This is a randomized trial of 134 individualized post-cesarean delivery who will be randomized to twice daily use of non-invasive bioelectronic treatment with TrueRelief device or identical appearing sham device for post-cesarean pain management.
What is the current status of trial NCT05250830?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2022-04-18. Estimated completion is 2023-04-16.
What interventions are being tested in trial NCT05250830?
The interventions under investigation include: TrueRelief device (DEVICE), Sham TrueRelief device (DEVICE).
Who is sponsoring clinical trial NCT05250830?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.